• About
    • Mission
    • Leadership
    • Careers
    • Clinical Advisory Board
    • News
    • Media & Press
    • Events
  • Viveve Solutions
    • Viveve System
    • InControl
  • Healthcare Providers
    • Clinical Studies
    • Become a Provider
    • Manage Your Listing
    • Hub Login
    • FAQs
    • Product Feedback
  • Patients
    • Blog
    • Find A Provider
    • Refer A Provider
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact Us
    • FAQs
    • Viveve Hub
    • Submit a Product Experience
  • Product Indication
Select Page
Viveve | US

Press Releases

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Publications
    • IR Calendar
    • Analyst Coverage
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Clinical Advisory Board
    • Medical Consultants
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Investor Presentation
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • Publications
  • IR Calendar
  • Analyst Coverage
  • Email Alerts

Viveve to Participate in the H.C. Wainwright Global Life Sciences Virtual Conference

Mar 2, 2021

Viveve Announces Preliminary Topline Financial Results for Fourth Quarter 2020

Feb 18, 2021

Viveve Recognized for Leadership in Appointing Women to Board of Directors

Feb 9, 2021

Viveve Announces Expansion of IP Portfolio with Issuance of S. Korean Patent

Feb 2, 2021

Viveve Regulatory Executive Named Among Top 25 Women Leaders in Medical Devices

Jan 28, 2021

Viveve Announces Initiation of Pivotal U.S. PURSUIT Trial in Stress Urinary Incontinence

Jan 21, 2021

Viveve Announces Closing of an Upsized $27.6 Million Underwritten Public Offering and Exercise of Over-Allotment Option

Jan 19, 2021

Viveve Announces Pricing of Upsized $24 Million Underwritten Public Offering

Jan 14, 2021

Viveve Regains Compliance with NASDAQ Continued Listing Rules

Dec 17, 2020

Viveve Announces FDA Approval of Proposed Amendments to Pivotal U.S. PURSUIT Trial Protocol

Dec 10, 2020
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...31

Viveve

A Global Women’s Intimate Health Company

Terms of Use | Privacy Policy
© 2021 Viveve Solutions. All Rights Reserved.

  • About
  • Viveve Solutions
  • Providers
  • Patients
  • Investors
  • Careers
  • Contact Us



  • Hub Login
  • Product Feedback

345 Inverness Drive South
Building B, Suite 250
Englewood, CO 80112

The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States.

The Viveve® System is an internationally patented cryogen-cooled monopolar radiofrequency (CMRF) energy-based platform device. It has received regulatory approvals and clearances in many countries throughout the world and is available through physician import license in Japan and China. In the United States the Viveve System is cleared by the FDA for general surgery procedures for electrocoagulation and hemostasis. International approvals and clearances include vaginal laxity and/or improvement of sexual function indications. In Argentina improvement of urinary incontinence in women is also an approved indication.

Translate »